Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki‐Järvinen
The Lancet Diabetes & Endocrinology (2014) Vol. 2, Iss. 11, pp. 901-910
Closed Access | Times Cited: 1130

Showing 26-50 of 1130 citing articles:

From NASH to diabetes and from diabetes to NASH: Mechanisms and treatment options
Amalia Gastaldelli, Kenneth Cusi
JHEP Reports (2019) Vol. 1, Iss. 4, pp. 312-328
Open Access | Times Cited: 351
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver
Paola Dongiovanni, Stefan Stender, Alessandro Pietrelli, et al.
Journal of Internal Medicine (2017) Vol. 283, Iss. 4, pp. 356-370
Open Access | Times Cited: 307
Non-alcoholic fatty liver disease: the interplay between metabolism, microbes and immunity
Herbert Tilg, Timon E. Adolph, Michael Dudek, et al.
Nature Metabolism (2021) Vol. 3, Iss. 12, pp. 1596-1607
Closed Access | Times Cited: 303
Non-alcoholic fatty liver disease
Naveed Sattar, Ewan Forrest, David Preiss
BMJ (2014) Vol. 349, Iss. sep19 15, pp. g4596-g4596
Open Access | Times Cited: 301
Interleukin‐1 and inflammasomes in alcoholic liver disease/acute alcoholic hepatitis and nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Herbert Tilg, Alexander R. Moschen, Gyöngyi Szabó
Hepatology (2016) Vol. 64, Iss. 3, pp. 955-965
Open Access | Times Cited: 281
Mouse Models of Nonalcoholic Steatohepatitis: Toward Optimization of Their Relevance to Human Nonalcoholic Steatohepatitis
Geoff Farrell, Jörn M. Schattenberg, Isabelle Leclercq, et al.
Hepatology (2018) Vol. 69, Iss. 5, pp. 2241-2257
Open Access | Times Cited: 277
Lipid droplet biogenesis and functions in health and disease
Armella Zadoorian, Ximing Du, Hongyuan Yang
Nature Reviews Endocrinology (2023) Vol. 19, Iss. 8, pp. 443-459
Open Access | Times Cited: 246
Autophagy in liver diseases: A review
Hui Qian, Xiaojuan Chao, Jessica A. Williams, et al.
Molecular Aspects of Medicine (2021) Vol. 82, pp. 100973-100973
Open Access | Times Cited: 244
Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors
Sven Francque, Gyöngyi Szabó, Manal F. Abdelmalek, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 18, Iss. 1, pp. 24-39
Closed Access | Times Cited: 242
Macrophages in obesity and non-alcoholic fatty liver disease: Crosstalk with metabolism
Sander Lefere, Frank Tacke
JHEP Reports (2019) Vol. 1, Iss. 1, pp. 30-43
Open Access | Times Cited: 234
Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity
Jean-Marc Schwarz, Susan M. Noworolski, Ayca Erkin‐Cakmak, et al.
Gastroenterology (2017) Vol. 153, Iss. 3, pp. 743-752
Open Access | Times Cited: 228
PPARs: Regulators of Metabolism and As Therapeutic Targets in Cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ
Lu Han, Wen‐Jun Shen, Stefanie Bittner, et al.
Future Cardiology (2017) Vol. 13, Iss. 3, pp. 279-296
Open Access | Times Cited: 226
Nonalcoholic Fatty Liver Disease and Metabolic Syndrome
Donghee Kim, Alexis Touros, W. Ray Kim
Clinics in Liver Disease (2017) Vol. 22, Iss. 1, pp. 133-140
Closed Access | Times Cited: 218
Extracellular Matrix Remodeling of Adipose Tissue in Obesity and Metabolic Diseases
Francisco Javier Ruiz‐Ojeda, Andrea Méndez-Gutiérrez, Concepción M. Aguilera, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 19, pp. 4888-4888
Open Access | Times Cited: 216
Metabolic Syndrome: Past, Present and Future
Isabelle Lemieux, Jean–Pierre Després
Nutrients (2020) Vol. 12, Iss. 11, pp. 3501-3501
Open Access | Times Cited: 216
Non-alcoholic fatty liver disease: A patient guideline
Sven Francque, Giulio Marchesini, Achim Kautz, et al.
JHEP Reports (2021) Vol. 3, Iss. 5, pp. 100322-100322
Open Access | Times Cited: 207
Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates
Pi‐Xiao Wang, Yan‐Xiao Ji, Xiao‐Jing Zhang, et al.
Nature Medicine (2017) Vol. 23, Iss. 4, pp. 439-449
Closed Access | Times Cited: 203
Potential of Chlorella as a Dietary Supplement to Promote Human Health
Tomohiro Bito, Eri Okumura, Masaki Fujishima, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2524-2524
Open Access | Times Cited: 199
Activation of the STING-IRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease
Jingting Qiao, Chen Cui, Ling Qing, et al.
Metabolism (2017) Vol. 81, pp. 13-24
Closed Access | Times Cited: 196
Dietary carbohydrates and fats in nonalcoholic fatty liver disease
Hannele Yki‐Järvinen, Panu K. Luukkonen, Leanne Hodson, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 11, pp. 770-786
Open Access | Times Cited: 193
Metabolically Healthy Obesity and the Development of Nonalcoholic Fatty Liver Disease
Yoosoo Chang, Hyun Suk Jung, Juhee Cho, et al.
The American Journal of Gastroenterology (2016) Vol. 111, Iss. 8, pp. 1133-1140
Closed Access | Times Cited: 191
Adipose tissue: between the extremes
Alexandros Vegiopoulos, Maria Rohm, Stephan Herzig
The EMBO Journal (2017) Vol. 36, Iss. 14, pp. 1999-2017
Open Access | Times Cited: 185
Effect of a ketogenic diet on hepatic steatosis and hepatic mitochondrial metabolism in nonalcoholic fatty liver disease
Panu K. Luukkonen, Sylvie Dufour, Kun Lyu, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 13, pp. 7347-7354
Open Access | Times Cited: 185
Phenotypes of prediabetes and stratification of cardiometabolic risk
Norbert Stefan, Andreas Fritsche, Fritz Schick, et al.
The Lancet Diabetes & Endocrinology (2016) Vol. 4, Iss. 9, pp. 789-798
Closed Access | Times Cited: 184
Nonalcoholic Fatty Liver Disease: Modulating Gut Microbiota to Improve Severity?
Judith Aron‐Wisnewsky, Moritz V. Warmbrunn, Max Nieuwdorp, et al.
Gastroenterology (2020) Vol. 158, Iss. 7, pp. 1881-1898
Open Access | Times Cited: 183

Scroll to top